Trial Profile
A prospective study evaluating the efficacy and safety of Idursulfase in Polish patients with Mucopolysaccharidosis type II (Hunter syndrome)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Idursulfase (Primary)
- Indications Mucopolysaccharidosis II
- Focus Adverse reactions; Therapeutic Use
- 09 Feb 2016 New trial record